Zobrazeno 1 - 10
of 91
pro vyhledávání: '"Sharon Melamed"'
Autor:
Hadas Tamir, Tal Noy-Porat, Sharon Melamed, Lilach Cherry-Mimran, Moria Barlev-Gross, Ron Alcalay, Yfat Yahalom-Ronen, Hagit Achdout, Boaz Politi, Noam Erez, Shay Weiss, Ronit Rosenfeld, Eyal Epstein, Ohad Mazor, Efi Makdasi, Nir Paran, Tomer Israely
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-10 (2024)
Abstract The eradication of smallpox was officially declared by the WHO in 1980, leading to discontinuation of the vaccination campaign against the virus. Consequently, immunity against smallpox and related orthopoxviruses like Monkeypox virus gradua
Externí odkaz:
https://doaj.org/article/6a40b8cca9af49db9e076e3f3cd2d842
Autor:
Noam Erez, Hagit Achdout, Yfat Yahalom-Ronen, Shimrit Adutler-Lieber, Liat Bar-On, Erez Bar-Haim, Boaz Politi, Einat B. Vitner, Hadas Tamir, Sharon Melamed, Nir Paran, Tomer Israely
Publikováno v:
Current Issues in Molecular Biology, Vol 45, Iss 10, Pp 7944-7955 (2023)
Following viral infection, T-cells are crucial for an effective immune response to intracellular pathogens, including respiratory viruses. During the COVID-19 pandemic, diverse assays were required in pre-clinical trials to evaluate the immune respon
Externí odkaz:
https://doaj.org/article/0ddd3a5019d54197809ada8edf944d5e
Autor:
Yfat Yahalom-Ronen, Sharon Melamed, Boaz Politi, Noam Erez, Hadas Tamir, Liat Bar-On, Julia Ryvkin, Dena Leshkowitz, Ofir Israeli, Shay Weiss, Amir Ben-Shmuel, Moria Barlev-Gross, Lilach Cherry Mimran, Hagit Achdout, Nir Paran, Tomer Israely
Publikováno v:
Vaccines, Vol 12, Iss 5, p 491 (2024)
The emergence of rapidly spreading variants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) poses a major challenge to vaccines’ protective efficacy. Intramuscular (IM) vaccine administration induces short-lived immunity but does no
Externí odkaz:
https://doaj.org/article/ccbee9186e4046ce9cc3fc09694d1712
Autor:
Tal Noy-Porat, Hadas Tamir, Ron Alcalay, Ronit Rosenfeld, Eyal Epstein, Lilach Cherry, Hagit Achdout, Noam Erez, Boaz Politi, Yfat Yahalom-Ronen, Shay Weiss, Sharon Melamed, Tomer Israely, Ohad Mazor, Nir Paran, Efi Makdasi
Publikováno v:
Microbiology Spectrum, Vol 11, Iss 5 (2023)
ABSTRACT Members of the Orthopoxvirus genus can cause severe infections in humans. Global vaccination against smallpox, caused by the variola virus, resulted in the eradication of the disease in 1980. Shortly thereafter, vaccination was discontinued,
Externí odkaz:
https://doaj.org/article/9ae3c1ac218b462d9e1b5066a2ed8763
Autor:
Romano Strobelt, Julia Adler, Nir Paran, Yfat Yahalom-Ronen, Sharon Melamed, Boaz Politi, Ziv Shulman, Dominik Schmiedel, Yosef Shaul
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-11 (2022)
Abstract The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causal agent of the COVID-19 pandemic. More than 274 million individuals have suffered from COVID-19 and over five million people have died from this disease so far. The
Externí odkaz:
https://doaj.org/article/a826cd1f56924ec59b2c5a34859e5f55
Autor:
Itai Glinert, Amir Ben-Shmuel, Moran Szwartcwort-Cohen, Adi Beth-din, Orly Laskar, Moria Barlev-Gross, Sharon Melamed, Noga Arbell, Haim Levy, Netanel A Horowitz, Shay Weiss
Publikováno v:
International Journal of Infectious Diseases, Vol 118, Iss , Pp 211-213 (2022)
SARS-CoV-2 Omicron strain emergence raised concerns that its enhanced infectivity is partly due to altered spread/contamination modalities. We therefore sampled high-contact surfaces and air in close proximity to patients who were verified as infecte
Externí odkaz:
https://doaj.org/article/4849bc671f57453380d55729b3ecfbe3
Autor:
Hagit Achdout, Einat. B. Vitner, Boaz Politi, Sharon Melamed, Yfat Yahalom-Ronen, Hadas Tamir, Noam Erez, Roy Avraham, Shay Weiss, Lilach Cherry, Erez Bar-Haim, Efi Makdasi, David Gur, Moshe Aftalion, Theodor Chitlaru, Yaron Vagima, Nir Paran, Tomer Israely
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-10 (2021)
Influenza A virus (IAV) and SARS-CoV-2 coinfection is a possible scenario during influenza season. Here, the authors show in a mouse model that IAV infection increases the risk of severe disease upon SARS-CoV-2 infection two days later. IAV vaccinati
Externí odkaz:
https://doaj.org/article/1c21769ac0654cd898e2ff49db5bd690
Autor:
Yfat Yahalom-Ronen, Hadas Tamir, Sharon Melamed, Boaz Politi, Hagit Achdout, Noam Erez, Ofir Israeli, Inbar Cohen-Gihon, Lilach Chery Mimran, Moria Barlev-Gross, Michal Mandelboim, Irit Orr, Ester Feldmesser, Shay Weiss, Adi Beth-Din, Nir Paran, Tomer Israely
Publikováno v:
Viruses, Vol 15, Iss 6, p 1364 (2023)
Since the emergence of the original SARS-CoV-2, several variants were described, raising questions as to the ability of recently developed vaccine platforms to induce immunity and provide protection against these variants. Here, we utilized the K18-h
Externí odkaz:
https://doaj.org/article/f1961a29be2c4c9e8151a1feefcdc500
Autor:
Ronit Rosenfeld, Tal Noy-Porat, Adva Mechaly, Efi Makdasi, Yinon Levy, Ron Alcalay, Reut Falach, Moshe Aftalion, Eyal Epstein, David Gur, Theodor Chitlaru, Einat B. Vitner, Sharon Melamed, Boaz Politi, Ayelet Zauberman, Shirley Lazar, Adi Beth-Din, Yentl Evgy, Shmuel Yitzhaki, Shmuel C. Shapira, Tomer Israely, Ohad Mazor
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-9 (2021)
Here, using the K18-hACE2 transgenic mice model, the authors report the in vivo efficacy of a fully human neutralizing antibody against SARS-CoV-2 and show that when administered before or up to 3 days post infection, treated mice do not exhibit dise
Externí odkaz:
https://doaj.org/article/46809b3d714542f1b041f07ea3d49be0
Autor:
Yfat Yahalom-Ronen, Hadas Tamir, Sharon Melamed, Boaz Politi, Ohad Shifman, Hagit Achdout, Einat B. Vitner, Ofir Israeli, Elad Milrot, Dana Stein, Inbar Cohen-Gihon, Shlomi Lazar, Hila Gutman, Itai Glinert, Lilach Cherry, Yaron Vagima, Shirley Lazar, Shay Weiss, Amir Ben-Shmuel, Roy Avraham, Reut Puni, Edith Lupu, Elad Bar-David, Assa Sittner, Noam Erez, Ran Zichel, Emanuelle Mamroud, Ohad Mazor, Haim Levy, Orly Laskar, Shmuel Yitzhaki, Shmuel C. Shapira, Anat Zvi, Adi Beth-Din, Nir Paran, Tomer Israely
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-13 (2020)
Here, the authors generate a replication-competent VSV based vaccine expressing SARS-CoV-2 spike protein and show protection in the hamster model with one dose. Analysis of the antibody response in mice shows induction of neutralizing antibodies and
Externí odkaz:
https://doaj.org/article/c9dbfd8736364f25b7884f0d5634e9e1